The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 01, 2022

Filed:

May. 24, 2018
Applicant:

Beijing Greatsun Bio-pharm. Tech. Co., Ltd, Beijing, CN;

Inventors:

Qiang Zhang, Beijing, CN;

Cuishuan Wu, Beijing, CN;

Yue Su, Beijing, CN;

Changjin Lee, Gangwon-Do, KR;

Guanghua Cui, Beijing, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/704 (2006.01); A61K 47/64 (2017.01); A61K 9/127 (2006.01);
U.S. Cl.
CPC ...
A61K 31/704 (2013.01); A61K 9/1271 (2013.01); A61K 47/64 (2017.08);
Abstract

The present invention relates to a long-circulating liposome modified with c(RGD-ACP-K). The present invention pertains to the field of pharmaceutical preparations, in particular to the field of targeted pharmaceutical preparations. More specifically, the present invention relates to a long-circulating liposome, the surface of the liposome being modified with c(RGD-ACP-K), and the liposome comprising doxorubicin or a pharmaceutically acceptable salt thereof such as doxorubicin hydrochloride as an anti-cancer active agent. The long-circulating liposome can targetedly deliver the anti-cancer active agent into tumor neovascular endothelial cells and tumor cells and can prolong the circulation time of the liposome in vivo, thereby enhancing the therapeutic effect of anti-tumor medicaments.


Find Patent Forward Citations

Loading…